Keywords:
Breast, Mammography, Ultrasound, Biopsy, Treatment effects, Cancer, Outcomes
Authors:
E. Castro López, M. A. Maestro Durán, J. MOSQUERA OSES, J. R. Varela Romero, D. Dominguez Conde; A Coruña/ES
DOI:
10.26044/ecr2019/C-1394
Aims and objectives
Breast cancer is the most common primary tumour in women.
Its incidence increases with age,
with almost one half appearing in women older than 65 years old.
It is the most important risk factor for most women.
As the age increases,
so do their comorbidities and surgical risk,
as well as their physiological reserves diminishes.This is the reason why sometimes it is not possible to follow the optimal treatment option.
However,
there is a higher rate of low-risk tumours in older women compared with younger ones.
Treatments often need a multidisciplinary approach involving specialists as surgeons,
oncologists,
radiotherapists and radiologists[1].
As we know,
there are major factors to be considered before making treatment decisions such as life expectancy,
psychological stress or functional status.
The first objective of this study was to analyse the efficacy and evolution of tumours in those women treated with hormone therapy,
giving letrozole as drug in most cases,
for their contraindications to undergo the treatment of choice.
Secondly,
we wanted to calculate the survival rate.
Related to this,
it has to be taken into account that we are studying elderly people,
in which it has been proved that breast cancer does not entirely lead to death.